InvestorsHub Logo
Followers 245
Posts 13854
Boards Moderated 0
Alias Born 04/26/2008

Re: greenwillow post# 1302

Tuesday, 08/14/2018 9:16:56 AM

Tuesday, August 14, 2018 9:16:56 AM

Post# of 2523
News! :) ask and u receive...

https://www.ehave.com/news/companion-animal-informatics-platform-update-to-include-medical-cannabis/

Ehave, Inc. (OTCQB: EHVVF), a healthcare company dedicated to empowering the medical cannabis and mental health communities with next-generation digital solutions, today gave an update on the development of its veterinary informatics solution for Companion Healthcare Technologies, Inc. (CHT), a company engaged in partnering, licensing and incubating cutting edge healthcare technologies to improve the quality of care for pets. CHT has licensed Ehave’s core health informatics platform, and the companies together have begun their work in developing a solution to effectively monitor, utilize, and improve therapeutic outcomes for pets by capturing and analyzing real-time, objective patient data.

?

CHT and Ehave have identified the emerging market opportunity for the use of medical cannabis in the care of companion animals, and the development of the informatics platform enhancements will incorporate the tracking of safety and efficacy data for animals who are prescribed cannabis. In addition, Ehave Connect platform’s capabilities in managing clinical trials will enable CHT’s customers to efficiently capture, track and manage high quality comprehensive data that can prove that cannabis works for pets.

“We have seen the recent market activity supporting the study and creation of safe and effective cannabis products for pets,” said Prateek Dwivedi, CEO of Ehave. “The Ehave platform for veterinary informatics that CHT has licensed will now embrace our core cannabis expertise. For day-to-day companion healthcare, trials of new cannabis therapies for pets, and the study of companion animals in pre-clinical trials for human cannabis therapeutics – the Ehave platform will ensure that reliable data exists a for clinicians to understand what to prescribe, pet owners to feel confident in treatments, and drug developers to design new therapies.”

Under the license agreement, CHT has exclusive rights to Ehave’s informatics platform for use, in any indication, in companion animals. Development has begun to integrate Ehave’s platform across the entire companion animal clinical pathway and related developments in the acceleration of quality of healthcare; allowing for consistent, consolidated data acquisition and analysis.